Viewing Study NCT00645151


Ignite Creation Date: 2025-12-24 @ 11:57 PM
Ignite Modification Date: 2026-01-04 @ 2:54 AM
Study NCT ID: NCT00645151
Status: COMPLETED
Last Update Posted: 2021-02-18
First Post: 2008-03-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Of The Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High Cholesterol
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2004-04
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: 2005-02
Completion Date Type: ACTUAL
First Submit Date: 2008-03-25
First Submit QC Date: None
Study First Post Date: 2008-03-27
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-02-17
Last Update Post Date: 2021-02-18
Last Update Post Date Type: ACTUAL